NASDAQ
Arena Pharmaceuticals, Inc. (ARNA) has a current ratio of 8.59x as of Tuesday, May 26, 2026. This represents a 38.45% decrease compared to its 12-month average of 13.95x. The current ratio measures a company's ability to cover short-term obligations by comparing current assets to current liabilities.
No price data available for this timeframe.